Three Blue Chip Stocks That Have Increased by 380% or More in the Last Five Years
Stock Performance: Nvidia, Oracle, and Eli Lilly have seen significant stock price increases over the past five years, with returns exceeding 380% for investors who bought in 2020, showcasing the potential of blue chip stocks for long-term gains.
Nvidia's Growth: Nvidia has become the most valuable company globally, driven by its leadership in AI chip production, with earnings soaring from under $5 billion to nearly $87 billion in the past year, while maintaining a reasonable forward P/E ratio.
Oracle's Adaptation: Oracle has successfully transitioned to provide cloud infrastructure and AI-related services, with its earnings nearly doubling in three years, and is launching an "Oracle AI Database" to meet evolving customer needs.
Eli Lilly's Innovation: Eli Lilly has transformed its business through the development of GLP-1 drugs for weight loss and diabetes, achieving significant earnings growth and presenting itself as a compelling investment opportunity with a lower forward P/E compared to its peers.
Trade with 70% Backtested Accuracy
Analyst Views on NVDA
About NVDA
About the author

- Strong Dow Performance: The Dow Jones Industrial Average gained 8.9% in the first half of 2026, marking its best performance since 2021, indicating a robust recovery in the U.S. stock market that may attract more investor interest.
- ETF Investment Opportunity: The SPDR Dow Jones Industrial Average ETF (DIA) offers exposure to these 30 blue-chip stocks, boasting an annualized return of 22.5% over the past year, while maintaining a low expense ratio of 0.16%, though investors should be cautious of its concentration risk.
- Market Comparison Analysis: Compared to the S&P 500 and Nasdaq-100, DIA's portfolio is concentrated in 30 stocks, lacking diversification, which could expose investors to greater risks during market volatility, especially given the strong performance of tech stocks.
- Cautious Investment Advice: While the Dow is often viewed as a barometer of the U.S. stock market, analysts suggest that investors should consider a broader portfolio when selecting ETFs, particularly those with greater long-term growth potential, as DIA is not recommended as the best choice.
- Shorting Tech Stocks: Notable investor Michael Burry disclosed short positions against Nvidia, Tesla, and Micron on his Substack, reflecting concerns over the AI trade, particularly as these stocks reach historical valuation extremes.
- Micron's Impressive Earnings: Micron's fiscal Q3 revenue surged over fourfold year-over-year to $41.5 billion; however, Burry argues that its stock price remains above historical averages, suggesting that market optimism about its future profitability may be overly optimistic.
- Tesla Delivery Figures: Tesla delivered 480,126 vehicles in Q2, a 25% year-over-year increase, yet its stock trades at over 350 times earnings, indicating high market expectations for future profitability, which Burry questions.
- Nvidia's Strong Growth: Nvidia's fiscal Q1 revenue rose 85% year-over-year to $81.6 billion, yet its stock trades at a 30 times earnings multiple, leading Burry to suggest that such valuations may not be sustainable, especially if the market's enthusiasm for AI proves to be a bubble.
- Market Potential: Citi analysts project that the total addressable market for CPUs will grow from approximately $29 billion to over $131 billion by 2030, indicating a significant surge in demand for CPUs as AI workloads evolve, positioning AMD's EPYC processors to benefit and solidify its role in AI infrastructure.
- Customer Expansion Speculation: Analysts speculate that AMD may announce partnerships with frontier AI labs for the adoption of its MI series chips, which could diversify AMD's customer base and optimize costs, although such announcements remain uncertain.
- Strong Stock Performance: By mid-2026, AMD's stock has appreciated by 159%, resulting in a forward P/E ratio of 75, indicating that the market is pricing in substantial future success and reflecting investor confidence in AMD's prospects within the AI ecosystem.
- Investment Strategy Advice: While AMD presents compelling opportunities in AI, analysts recommend a dollar-cost averaging strategy rather than attempting to time purchases, allowing investors to benefit from the expanding CPU market and AMD's potential market share growth over the long term.
- Significant Market Potential: According to Goldman Sachs, the weight loss drug market could reach $95 billion by 2030, while J.P. Morgan estimates the broader GLP-1 market at nearly $200 billion, with Viking's VK2735 potentially capturing 1% of the market, translating to $1.5 billion in annual sales.
- Investment Return Expectations: If VK2735 successfully launches and achieves a price-to-sales ratio of 10, Viking's market cap could rise from $4.4 billion to $15 billion, suggesting that a $1,000 investment could grow to approximately $3,400, although risks of share dilution remain.
- Intense Competitive Landscape: VK2735 faces fierce competition from Eli Lilly and Novo Nordisk, whose drugs have demonstrated significant weight loss in clinical trials, necessitating VK2735 to offer clear advantages in efficacy, pricing, and tolerability to gain market share.
- Slow Clinical Trial Progress: The phase 3 trial for VK2735's injectable form is not expected to complete until 2027, while oral trials are just beginning; failure to replicate favorable data in larger cohorts could lead to a significant drop in investor confidence, potentially reducing a $1,000 investment to a few hundred dollars.
- Short Position Disclosure: Renowned hedge fund manager Michael Burry revealed his short positions against Nvidia, Tesla, and Applied Materials this week, indicating strong skepticism towards AI-related stocks, particularly as their valuations reach historical highs.
- Micron Technology Risks: Burry highlighted that Micron's stock trades significantly above its 200-day moving average, with its fiscal Q3 revenue soaring over 400% year-over-year to $41.5 billion; however, he believes such high earnings levels are unsustainable and may face downside risks.
- Nvidia Valuation Defense: Despite Nvidia's fiscal Q1 revenue rising 85% year-over-year to $81.6 billion, with data center revenue climbing 92%, its stock trades at about 30 times earnings, leading Burry to question whether this high valuation can be maintained amid potential AI bubble concerns.
- Tesla Profitability Challenges: Tesla delivered 480,126 vehicles in Q2, up 25% year-over-year, yet its stock fell 7.5%, with Burry arguing that its high price-to-earnings ratio exceeding 350 times raises significant risks, especially if future profitability from robotaxi and software services is delayed.
- Short Position Disclosure: Renowned investor Michael Burry revealed his short positions against Nvidia, Tesla, Applied Materials, Caterpillar, and the iShares Semiconductor ETF on his Substack, indicating a strong skepticism towards AI-related stocks that may prompt a market reassessment of these equities.
- Micron Technology Risks: Burry highlighted that Micron's stock trades significantly above its 200-day moving average, with revenue in fiscal Q3 2026 soaring over 400% year-over-year to $41.5 billion; however, he argues that such high earnings levels are unlikely to be sustainable, posing downside risks.
- Nvidia Valuation Controversy: Despite Nvidia's fiscal Q1 2026 revenue surging 85% year-over-year to $81.6 billion, with data center revenue climbing 92%, the stock trades at about 30 times earnings, leading Burry to question whether this high valuation can endure, especially amid concerns of an AI bubble.
- Tesla Profitability Pressure: Tesla delivered 480,126 vehicles in Q2, up 25% year-over-year, yet its stock fell 7.5% on the report day; Burry believes its 350 times earnings valuation is excessive, and future profit growth expectations may be overly optimistic, warranting caution from investors.











